Published March 18, 2024 | Version v1
Journal article Open

Antibody Characterization Report for SHIP1 (INPP5D)

  • 1. ROR icon Montreal Neurological Institute and Hospital
  • 2. Brigham and Women's Hospital and Harvard Medical School
  • 3. ROR icon McGill University

Description

This report presents a guide to selecting high-quality commercial antibodies against Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP1), encoded by INPP5D, by Western blot and immunoprecipitation, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls.

Work presented in this report was supported in part by the Accelerating Medicines Partnership Program for Alzheimers Disease (AMD-AD) established by the National Institutes of Aging under award number U54AG065187.

Files

SHIP1_INPP5D_YCharOS report_v4.pdf

Files (4.0 MB)

Name Size Download all
md5:f854dad082e649a4ab9793c1e087fa16
4.0 MB Preview Download

Additional details

Dates

Submitted
2024-03-18